Earnings Feed
Start Free
Home/Insiders/MCNAB JAMES R
MJ
SEC Insider//CIK 0001190126

MCNAB JAMES R

CIK 00011901263 companiesCAMBRIDGE, MA
SEC Profile

Transactions

50

Companies

3

Filings

10

CIK

0001190126

Recent Transactions

50 trades
  • Other
    TITAN PHARMACEUTICALS INC$TTNP

    Common Stock

    2022-01-28+51,021→ 51,021 total
  • Award
    TITAN PHARMACEUTICALS INC$TTNP

    Option to Purchase Common Stock

    2022-01-05+10,000→ 10,000 total
  • Award
    TITAN PHARMACEUTICALS INC$TTNP

    Option to Purchase Common Stock

    2021-02-10+25,000→ 25,000 total
  • Purchase
    TITAN PHARMACEUTICALS INC$TTNP

    Common Stock

    2018-09-21$0.25/sh+200,000→ 300,000 total
  • Award
    TITAN PHARMACEUTICALS INC$TTNP

    Warrants

    2018-09-21+200,000→ 200,000 total
  • Award
    TITAN PHARMACEUTICALS INC$TTNP

    Option to Purchase Common Stock

    2017-09-15+10,000→ 10,000 total
  • Sale
    CURIS INC$CRIS

    Common Stock

    2017-05-05$1.90/sh−16,176→ 50,000 total
  • Sale
    CURIS INC$CRIS

    Common Stock

    2017-05-05$1.90/sh−16,176→ 50,000 total
  • Sale
    CURIS INC$CRIS

    Common Stock

    2017-05-04$1.97/sh−30,100→ 66,176 total
  • Sale
    CURIS INC$CRIS

    Common Stock

    2017-05-04$1.97/sh−30,100→ 66,176 total
  • Sale
    CURIS INC$CRIS

    Common Stock

    2017-05-03$2.18/sh−30,000→ 96,276 total
  • Sale
    CURIS INC$CRIS

    Common Stock

    2017-05-03$2.18/sh−30,000→ 96,276 total
  • Sale
    CURIS INC$CRIS

    Common Stock

    2017-05-02$2.31/sh−35,646→ 126,276 total
  • Sale
    CURIS INC$CRIS

    Common Stock

    2017-05-01$2.38/sh−38,113→ 161,922 total
  • Sale
    CURIS INC$CRIS

    Common Stock

    2017-04-28$2.45/sh−42,949→ 200,035 total
  • Sale
    CURIS INC$CRIS

    Common Stock

    2017-04-27$2.57/sh−37,202→ 242,984 total
  • Sale
    CURIS INC$CRIS

    Common Stock

    2017-04-26$2.65/sh−32,738→ 879,688 total
  • Sale
    CURIS INC$CRIS

    Common Stock

    2017-04-26$2.65/sh−19,814→ 280,186 total
  • Sale
    CURIS INC$CRIS

    Common Stock

    2017-04-25$2.60/sh−56,940→ 912,426 total
  • Sale
    CURIS INC$CRIS

    Common Stock

    2017-04-24$2.56/sh−42,076→ 1,269,366 total
  • Sale
    CURIS INC$CRIS

    Common Stock

    2017-04-24$2.56/sh−42,076→ 969,366 total
  • Sale
    CURIS INC$CRIS

    Common Stock

    2017-04-21$2.58/sh−45,705→ 1,011,442 total
  • Sale
    CURIS INC$CRIS

    Common Stock

    2017-04-21$2.58/sh−45,705→ 1,311,442 total
  • Sale
    CURIS INC$CRIS

    Common Stock

    2017-04-20$2.66/sh−22,541→ 1,057,147 total
  • Sale
    CURIS INC$CRIS

    Common Stock

    2017-04-20$2.66/sh−22,541→ 1,357,147 total
  • Award
    CURIS INC$CRIS

    Non-qualified stock option

    2017-02-28+120,000→ 120,000 total
  • Award
    TITAN PHARMACEUTICALS INC$TTNP

    Option to Purchase Common Stock

    2017-02-16+10,000→ 10,000 total
  • Purchase
    TITAN PHARMACEUTICALS INC$TTNP

    Common Stock

    2016-05-31$7.03/sh+20,000→ 100,000 total
  • Award
    CURIS INC$CRIS

    Non-qualified stock option

    2016-01-19+170,000→ 170,000 total
  • Purchase
    TITAN PHARMACEUTICALS INC$TTNP

    Common Stock

    2016-01-13$3.16/sh+16,363→ 80,000 total
  • Award
    TITAN PHARMACEUTICALS INC$TTNP

    Option to Purchase Common Stock

    2015-12-14+10,000→ 10,000 total
  • Award
    TITAN PHARMACEUTICALS INC$TTNP

    Option to Purchase Common Stock

    2015-03-16+12,500→ 12,500 total
  • Award
    CURIS INC$CRIS

    Non-qualified stock option (right to buy)

    2015-01-26+85,000→ 85,000 total
  • Award
    CURIS INC$CRIS

    Non-qualified stock option (right to buy)

    2014-01-27+85,000→ 85,000 total
  • Purchase
    CURIS INC$CRIS

    Common stock

    2013-08-16$4.00/sh+50,000→ 250,000 total
  • Sale
    CURIS INC$CRIS

    Common stock

    2013-08-16$4.00/sh−50,000→ 50,000 total
  • Award
    CURIS INC$CRIS

    Non-qualified stock option (right to buy)

    2013-01-17+85,000→ 85,000 total
  • Gift
    CURIS INC$CRIS

    Common stock

    2012-12-20−30,975→ 100,000 total
  • Sale
    CURIS INC$CRIS

    Common stock

    2012-06-19$4.76/sh−139,000→ 1,079,688 total
  • Sale
    CURIS INC$CRIS

    Common stock

    2012-06-18$4.75/sh−150,000→ 1,218,688 total
  • Sale
    CURIS INC$CRIS

    Common stock

    2012-06-15$4.73/sh−11,000→ 1,368,688 total
  • Exercise/Conversion
    CURIS INC$CRIS

    Common stock

    2012-01-30$2.15/sh+85,000→ 0 total
  • Exercise/Conversion
    CURIS INC$CRIS

    Common stock

    2012-01-30$2.43/sh+87,500→ 0 total
  • Exercise/Conversion
    CURIS INC$CRIS

    Non-qualified stock option (right to buy)

    2012-01-30$2.15/sh+85,000→ 0 total
  • Exercise/Conversion
    CURIS INC$CRIS

    Non-qualified stock option (right to buy)

    2012-01-30$2.27/sh+85,000→ 0 total
  • Exercise/Conversion
    CURIS INC$CRIS

    Common stock

    2012-01-30$2.27/sh+85,000→ 1,379,688 total
  • Exercise/Conversion
    CURIS INC$CRIS

    Non-qualified stock option (right to buy)

    2012-01-30$2.43/sh+87,500→ 0 total
  • Award
    CURIS INC$CRIS

    Non-qualified stock option (right to buy)

    2012-01-05+170,000→ 85,000 total
  • Sale
    CURIS INC$CRIS

    Common stock

    2011-03-31$3.25/sh−25,000→ 1,122,188 total
  • Sale
    CURIS INC$CRIS

    Common stock

    2011-03-30$3.28/sh−25,000→ 1,147,188 total

Companies

3

Recent Filings

10

Address

45 MOULTON STREET

CAMBRIDGE, MA, 02138

View on SEC.gov